JGC
MJN

J. Goldman & Co’s Mead Johnson Nutrition Company MJN Stock Holding History

J. Goldman & Co’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-77,500
Closed -$5.75M – 330
2013
Q3 		$5.75M Buy
+77,500
New +$5.81M 0.54% 48

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

J. Goldman & Co's MJN Position: Q4 2013 in Review

J. Goldman & Co sold out of Mead Johnson Nutrition Company (MJN) in Q4 2013, closing a stake of 77,500 shares — an estimated $5.75M sold.

J. Goldman & Co first reported a position in MJN in Q3 2013 and held it in 1 quarter. The position peaked at $5.75M in Q3 2013. 483 funds tracked by Wall St. Rank hold MJN as of Q4 2013.

  • J. Goldman & Co reported no remaining Mead Johnson Nutrition Company position as of Q4 2013 after selling out during the quarter.
  • J. Goldman & Co sold 77,500 Mead Johnson Nutrition Company shares in Q4 2013, an estimated $5.75M.
  • J. Goldman & Co first reported a position in Mead Johnson Nutrition Company in Q3 2013 and held it in 1 quarter.
  • J. Goldman & Co's Mead Johnson Nutrition Company position peaked at $5.75M in Q3 2013.
  • 483 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q4 2013.

Based on J. Goldman & Co's 13F filing for Q4 2013, filed 14 Feb 2014.